Journal of Hepatology
Volume 47, Issue 4 , Pages 447-450 , October 2007

Hepatocellular carcinoma in human immunodeficiency virus (HIV)-infected patients: Is it really different, and if so, why?

  • Françoise Degos

      Affiliations

    • Service d’Hépatologie, Hôpital Beaujon APHP, Clichy, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 140875527; fax: +33 147396178.
    • ,
  • Cristina Tural

      Affiliations

    • Internal Medicine Department/HIV Clinical Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, C/carretera del Canyet s/n, 08916 Badalona, Barcelona, Spain

References 

  1. Bräu N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.–Canadian multicenter study. J Hepatol. 2007;47:527–537
  2. Deffic-Burba S, Poynard T, Sulkowski MS, Wong JB. Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States. J Viral Hepat. 2007;14:107–115
  3. Powles T, Macdonald D, Nelson M, Stebbing J. Hepatocellular carcinoma in HIV-infected individuals: tomorrow’s problem?. Expert Rev Anticancer Ther. 2006;11:1553–1558
  4. Puoti M, Bruno R, Soriano V, Donato F, Gaeta GB, Quinzan GP, et al. Hepatocellular carcinoma in HIV patients: epidemiological features, clinical presentation and outcome. AIDS. 2004;18:2285–2293
  5. Alter M. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44:S6–S9
  6. Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis. 2005;192:992–1002
  7. Gotz HM, van Doornum G, Niesters HG, den Hollander JG, Thio HB, de Zwart O. A cluster of acute hepatitis C virus infection among men who have sex with men – results from contact tracing and public health implications. AIDS. 2005;19:969–974
  8. Rosenthal E, Pialoux G, Bernard N, Pradier C, Rey D, Bentata M, et al. Liver related mortality in human immunodeficiency virus infected patients between 1995 and 2003 in the French GERMIVIC joint study network. J Viral Hepat. 2007;14:183–188
  9. Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, Kirk O, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006;166:1632–1641
  10. Kramer JR, Giordano TP, Souchek J, Richardson P, Hwang LY, El Serag HB. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in US veterans with hepatitis C. Am J Gastroenterol. 2005;100:56–63
  11. Posthouwer D, Makris M, Yee TT, Fischer K, van Veen JJ, Griffioen A, et al. Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study. Blood. 2007;109:3667–3671
  12. Giordano TP, Kramer JR, Souchek J, Richardson P, El Serag HB. Cirrhosis and hepatocellular carcinoma in HIV veterans with and without the hepatitis C virus. Arch Intern Med. 2004;164:2349–2354
  13. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576
  14. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology. 2001;33:1358–1364
  15. Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Diabetes Care. 2007;30:113–119
  16. Qurishi N, Kreuzberg C, Luchters G, Effenberger W, Kupfer B, Sauerbruch T, et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. The Lancet. 2003;362:1708–1713
  17. Puoti M, Bruno R, Filice G, Carosi G. Natural history of chronic hepatitis B in coinfected patients. J Hepatol. 2006;44:S65–S70
  18. Massard J, Radziu V, Thabut D, Moussali J, Lebray P, Benhamou Y, et al. Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol. 2006;44:S19–S24
  19. Balasubramanian A, Koziel M, Groopman JE, Ganju RK. Molecular mechanism of hepatic injury in co infection with hepatitis C virus and HIV. Clin Infect Dis. 2005;41:S32–S37
  20. Francoz C, Belghiti J, Durand F. Indications of liver transplantation in patients with complications of cirrhosis. Best Pract Res Clin Gastroenterol. 2007;21:175–190
  21. Ettorre GM, Vennareecci G, Boschetto A, Giovanelli L, Antonini M, Carboni F. Resection and transplantation: evaluation of surgical perspectives in HIV positive patients affected by end-stage liver disease. J Exp Clin Cancer Res. 2003;22:S167–S169
  22. Bruno R, Puoti M, Sacchi P, Filice C, Carosi G, Filice G. Management of hepatocellular carcinoma in human immunodeficiency virus infected patients. J Hepatol. 2006;44:S41–S50
  23. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. The Lancet. 2003;362:1907–1917
  24. Beaugrand M, Sala M, Degos F, Sherman M, Bolondi L, Evans T, et al. Treatment of advanced hepatocellular carcinoma (HCC) by Seocalcitol (a vitamin D analogue). An international randomized double-blind, placebo-controlled study in 747 patients. J Hepatol. 2005;42:517
  25. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236
  26. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Raoul J, Zeuzem S, et al. For the SHARP Investigators Study Group. Sorafenib improves survival in advanced Hepatocellular Carcinoma (HCC): Results of a Phase III randomized placebo-controlled trial (SHARP trial). ASCO Proceedings 2007; LBA1.

☆ The authors declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.

PII: S0168-8278(07)00407-2

doi: 10.1016/j.jhep.2007.07.011

Journal of Hepatology
Volume 47, Issue 4 , Pages 447-450 , October 2007

Article Tools